Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

This publication has 39 references indexed in Scilit:

• Aspirin resistance: What, why and when?
  Thrombosis Research, 2007
• Comparison of Different Methods to Evaluate the Effect of Aspirin on Platelet Function in High-Risk Patients With Ischemic Heart Disease Receiving Dual Antiplatelet Treatment
  American Journal of Clinical Pathology, 2007
• The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting
  Journal of the American College of Cardiology, 2005
• Clopidogrel for Coronary Stenting
  Circulation, 2003
• Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement
  Thrombosis and Haemostasis, 2003
• Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin
  The American Journal of Cardiology, 2002
• Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100
  Blood Coagulation & Fibrinolysis, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease
  The American Journal of Cardiology, 2001
• Development of aspirin resistance in persons with previous ischemic stroke.
  Stroke, 1994